Endoscopic Submucosal Dissection Registry

Completed

Conditions studied: Gastrointestinal Neoplasms, Gastric Cancer

In brief

The purpose of this study is to monitor the success rates and completion rates for endoscopic submucosal dissection (ESD) for gastrointestinal (GI) cancers.

Key facts

Study ID

NCT01415609

Run by

Mayo Clinic

People needed

17

Starts

2010-08-01

Expected to finish

2012-03-01

Last updated by the study team

2012-11-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Use of antiplatelet(e.g. clopidrogel) or anticoagulation (e.g. Coumadin) agents that cannot be withheld for at least 7 days prior to the procedure. Aspirin use is accepted according to the American Society for Gastrointestinal Endoscopy for these procedures.
• Patients who refuse or who are unable to consent.
• Suboptimal colon prep, or solid gastric residual that precludes safe lesion resection at the time of endoscopy.
• Lesion location in a segment of the colon not conducive to ESD, including significant narrowing, tortuosity and/or extensive diverticular disease, as determined by the endoscopist.

Where it is running

• Mayo Clinic Florida — Jacksonville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.